1. Home
  2. WST vs KB Comparison

WST vs KB Comparison

Compare WST & KB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WST
  • KB
  • Stock Information
  • Founded
  • WST 1923
  • KB 2008
  • Country
  • WST United States
  • KB South Korea
  • Employees
  • WST N/A
  • KB N/A
  • Industry
  • WST Medical/Dental Instruments
  • KB Commercial Banks
  • Sector
  • WST Health Care
  • KB Finance
  • Exchange
  • WST Nasdaq
  • KB Nasdaq
  • Market Cap
  • WST 20.1B
  • KB 28.6B
  • IPO Year
  • WST N/A
  • KB N/A
  • Fundamental
  • Price
  • WST $284.86
  • KB $81.54
  • Analyst Decision
  • WST Strong Buy
  • KB
  • Analyst Count
  • WST 9
  • KB 0
  • Target Price
  • WST $354.50
  • KB N/A
  • AVG Volume (30 Days)
  • WST 719.2K
  • KB 105.9K
  • Earning Date
  • WST 10-23-2025
  • KB 10-23-2025
  • Dividend Yield
  • WST 0.31%
  • KB 2.42%
  • EPS Growth
  • WST 0.17
  • KB 37.07
  • EPS
  • WST 6.75
  • KB 10.86
  • Revenue
  • WST $3,017,900,000.00
  • KB $11,023,622,707.00
  • Revenue This Year
  • WST $6.49
  • KB $13.83
  • Revenue Next Year
  • WST $6.23
  • KB $1.93
  • P/E Ratio
  • WST $42.19
  • KB $7.21
  • Revenue Growth
  • WST 4.92
  • KB 10.10
  • 52 Week Low
  • WST $187.43
  • KB $46.38
  • 52 Week High
  • WST $348.90
  • KB $92.39
  • Technical
  • Relative Strength Index (RSI)
  • WST 58.99
  • KB 50.56
  • Support Level
  • WST $281.00
  • KB $80.51
  • Resistance Level
  • WST $322.34
  • KB $82.48
  • Average True Range (ATR)
  • WST 8.49
  • KB 1.42
  • MACD
  • WST 1.13
  • KB 0.10
  • Stochastic Oscillator
  • WST 42.20
  • KB 70.03

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

About KB KB Financial Group Inc

KB Financial Group Inc. is a financial holding company in Korea. The company operations include Kookmin Bank, one of the commercial banks in Korea. The company's subsidiaries collectively engage in a broad range of businesses, including commercial banking, credit cards, asset management, non-life and life insurance, capital markets activities, and international banking and finance. The company's segments include the Banking business, Securities business, Non-life Insurance business, Credit card business, and Life Insurance business. The Group generates the majority of its revenue from the Banking business.

Share on Social Networks: